[HTML][HTML] Air pollution and chronic airway diseases: what should people know and do?

XQ Jiang, XD Mei, D Feng - Journal of thoracic disease, 2016 - ncbi.nlm.nih.gov
The health effects of air pollution remain a public health concern worldwide. Exposure to air
pollution has many substantial adverse effects on human health. Globally, seven million …

[HTML][HTML] SmokeHaz: systematic reviews and meta-analyses of the effects of smoking on respiratory health

L Jayes, PL Haslam, CG Gratziou, P Powell, J Britton… - Chest, 2016 - Elsevier
Background Smoking tobacco increases the risk of respiratory disease in adults and
children, but communicating the magnitude of these effects in a scientific manner that is …

Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline

GJ Criner, J Bourbeau, RL Diekemper, DR Ouellette… - Chest, 2015 - Elsevier
BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …

Smoking cessation for people with chronic obstructive pulmonary disease

EAM van Eerd, RM van der Meer… - Cochrane Database …, 2016 - cochranelibrary.com
Background Smoking cessation is the most important treatment for smokers with chronic
obstructive pulmonary disease (COPD), but little is known about the effectiveness of different …

Screening for and early detection of chronic obstructive pulmonary disease

JB Soriano, J Zielinski, D Price - The Lancet, 2009 - thelancet.com
Chronic obstructive pulmonary disease (COPD) is a substantially underdiagnosed disorder,
with the diagnosis typically missed or delayed until the condition is advanced. Spirometry is …

Definition, epidemiology and natural history of COPD

G Viegi, F Pistelli, DL Sherrill, S Maio… - European …, 2007 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is the fifth cause of morbidity and mortality in
the developed world and represents a substantial economic and social burden. Patients …

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

HJ Aubin, A Bobak, JR Britton, C Oncken, CB Billing… - Thorax, 2008 - thorax.bmj.com
Background: Varenicline, a new treatment for smoking cessation, has demonstrated
significantly greater efficacy over placebo and sustained release bupropion (bupropion SR) …

Smoking cessation and COPD

P Tønnesen - European respiratory review, 2013 - Eur Respiratory Soc
The mainstay in smoking cessation is counselling in combination with varenicline, nicotine
replacement therapy (NRT) or bupropion SR. Varenicline and combination of two NRTs is …

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

CA Jiménez-Ruiz, S Andreas, KE Lewis… - European respiratory …, 2015 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary
tuberculosis are common pulmonary diseases that are caused or worsened by tobacco …

The life-course impact of smoking on hypertension, myocardial infarction and respiratory diseases

K Gao, X Shi, W Wang - Scientific reports, 2017 - nature.com
The objective of this study was to examine the impact of smoking on respiratory diseases,
hypertension and myocardial infarction, with a particular focus from a life-course …